Indegene Ltd.

530

-1.4 (-0.3%)growUp

INDGN Share Price
As on May 8, 2026
SectorHealthcare
IndustryHEALTHCARE SERVICES
Basic IndustryHealthcare Research Analytics & Technology
Market Cap12,768 Cr
P/E Ratio31.21
Dividend Yield0.19 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open531.4
High535
NSE SymbolINDGN
Close530
Low528.1
BSE Symbol544172
Previous Years High/Low
1 Year High632.9
3 Year High736.3
5 Year High736.3
1 Year Low414
3 Year Low414
5 Year Low414

Technicals


IndicatorsValueSignal
5-DMA534.45Bearish
10-DMA515.54Bullish
20-DMA502.7Bullish
50-DMA477.36Bullish
100-DMA490.04Bullish
200-DMA520.86Bullish

Historical Performance


1 Year
-3%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsMar-2025Mar-2024Mar-2023Mar-2022Mar-2021
Sales---------------
Operating Expenses1,7181,6812,0062,1441,194
Other Income1,072763582259306
Operating Profit6,4155,8174,5413,1282,612
Interest2204943136070
Depreciation802761598335255
Profit Before Tax5,3934,5863,6302,2652,315
Consolidated Net Profit4,0673,3672,6611,6481,494
Adjusted EPS17151278
Compounded Sales Growth
10 Years:64.8
5 Years:34.6
3 Years:11.3
TTM:1.9
Compounded Profit Growth
10 Years:85.9
5 Years:86.2
3 Years:19.8
TTM:3.8
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:-4.2
Return on Equity
10 Years:1.8
5 Years:7.6
3 Years:12
last year:17

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


ParticularsMar-2025Mar-2024Mar-2023Mar-2022Mar-2021
Share Capital47944444343
Total Reserves25,31613,53310,0177,5783,198
Long-Term Borrowings---------------
Total Non-Current Liabilities5604,3485,839800268
Other Current Liabilities3,9534,0253,5433,0551,284
Short Term Borrowings---97---------
Total Liabilities32,36124,74821,36812,8435,593
Capital Work in Progress36------------
Long Term Loans & Advances224350203165140
Currents Investments12,8977,9656,1401,199---
Short Term Loans and Advances601339362656
Total Current Assets25,30017,90814,48711,3004,593
Total Assets32,36124,74821,36812,8435,593
Adjusted Book Value10863473416
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 31.21, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -3.6%, indicating poor shareholder returns.
  • The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹6415 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹28393 million, indicating a large and established business.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 933098.6
No. of Shares: 1761 (Approx)
Performance:-6.7%
P/L: ₹-66901.4
NIFTY Performance: 0.7%
1 day Top Gainers
SymbolChange%
FSL274.26(17%)
THERMAX4677.5(12%)
NUVAMA1631.5(11%)
SONATSOFTW297.15(10%)
METROPOLIS549.5(9%)
1 Day Top Losers
SymbolChange%
DALBHARAT1823.6(-8%)
CCL1123.1(-7%)
SBIN1019.3(-7%)
ABREL1485.8(-7%)
ESCORTS3146.6(-6%)
ACMESOLAR282.8(-5%)
BRITANNIA5520(-5%)
INOXINDIA1483.2(-5%)

Top Performing Stocks from the same sector


Vijaya Diagnostic Centre Ltd.

32.8%

1278.9

1 Month Performance

Suven Life Sciences Ltd.

31.9%

222.98

1 Month Performance

Thyrocare Technologies Ltd.

24.6%

486.5

1 Month Performance

Yatharth Hospital & Trauma Care Services Ltd.

22.7%

862.2

1 Month Performance

Metropolis Healthcare Ltd.

20.5%

549.5

1 Month Performance

Dr. Lal Pathlabs Ltd.

19.7%

1649.8

1 Month Performance

Artemis Medicare Services Ltd.

15.7%

265.67

1 Month Performance

Vimta Labs Ltd.

15.5%

512.2

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month